Summit Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Summit Financial's PFE Position: Q2 2026 in Review
Summit Financial increased its Pfizer (PFE) stake by 14% in Q2 2026, buying an estimated $615K and bringing the position to 192,213 shares worth $4.63M. The position accounts for 0.05% of the portfolio, ranked #364.
Summit Financial first reported a position in PFE in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.74M in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Summit Financial held 192,213 shares of Pfizer worth $4.63M as of Q2 2026.
- Summit Financial bought 23,510 Pfizer shares in Q2 2026, an estimated $615K.
- Pfizer made up 0.05% of Summit Financial's portfolio in Q2 2026, its #364 holding.
- Summit Financial first reported a position in Pfizer in Q2 2021 and has held it in 21 quarters since.
- Summit Financial's Pfizer position peaked at $4.74M in Q1 2026.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.